V
Vassilis Voudris
Publications - 163
Citations - 5568
Vassilis Voudris is an academic researcher. The author has contributed to research in topics: Coronary artery disease & Percutaneous coronary intervention. The author has an hindex of 31, co-authored 157 publications receiving 4997 citations.
Papers
More filters
Journal ArticleDOI
Intravascular ultrasound-guided optimized stent deployment Immediate and 6 months clinical and angiographic results from the Multicenter Ultrasound Stenting in Coronaries Study (MUSIC Study)
P. de Jaegere,Harald Mudra,H. R. Figulla,Yaron Almagor,S. Doucet,Ian M. Penn,Antonio Colombo,Christian W. Hamm,Antonio L. Bartorelli,Martin T. Rothman,Masakiyo Nobuyoshi,T. Yamaguchi,Vassilis Voudris,C. DiMario,S. Makovski,Dirk Hausmann,S. Rowe,S. Rabinovich,Madoka Sunamura,G.A. van Es +19 more
TL;DR: These data confirm that, in selected patients, stents can safely be implanted without the use of systemic anticoagulation, provided optimal stent expansion is achieved.
Journal ArticleDOI
Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices
Konstantinos Farsalinos,Alketa Spyrou,Kalliroi Tsimopoulou,Christos Stefopoulos,Giorgio Romagna,Vassilis Voudris +5 more
TL;DR: The need for higher levels of nicotine-containing liquids (approximately 50 mg/ml) in order to deliver nicotine more effectively and approach the nicotine-delivery profile of tobacco cigarettes is supported.
Journal ArticleDOI
Characteristics, Perceived Side Effects and Benefits of Electronic Cigarette Use: A Worldwide Survey of More than 19,000 Consumers
Konstantinos Farsalinos,Giorgio Romagna,Dimitris Tsiapras,Stamatis Kyrzopoulos,Vassilis Voudris +4 more
TL;DR: It is indicated that ECs are mostly used to avoid the harm associated with smoking and can be effective even in highly-dependent smokers and are used as long-term substitutes for smoking.
Journal ArticleDOI
Ascorbic Acid Prevents Contrast-Mediated Nephropathy in Patients With Renal Dysfunction Undergoing Coronary Angiography or Intervention
Konstantinos Spargias,Elias Alexopoulos,Stamatis Kyrzopoulos,Panayiotis Iacovis,Darren C. Greenwood,Athanassios Manginas,Vassilis Voudris,Gregory Pavlides,Christopher E. Buller,Dimitrios Th. Kremastinos,Dennis V. Cokkinos +10 more
TL;DR: Prophylactic oral administration of ascorbic acid may protect against contrast-mediated nephropathy in high-risk patients undergoing a coronary procedure.
Journal ArticleDOI
Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial
Pieter C. Smits,Sjoerd H. Hofma,Mario Togni,Nicolás Vázquez,Mariano Valdés,Vassilis Voudris,Ton Slagboom,Jean-Jaques Goy,Andre Vuillomenet,Antoni Serra,Ramiro Trillo Nouche,Peter den Heijer,Martin van der Ent +12 more
TL;DR: Biodegradable polymer biolimus-eluting stents are as safe and efficacious as the current standard of a thin-strut everolimus-Eluting stent with a durable biocompatible polymer.